T-cell lymphoma: autologous or allogeneic transplant?
Francine Foss
2:27
What are the challenges of integrating therapy around autologous transplantation?
John Kuruvilla
1:03
What is induction therapy for autologous stem cell transplanation?
Michele Cavo
4:59
Conflicting results of the EMN02 and staMINA trials
Michele Cavo
2:50
Current standard of care for patients who are eligible for autologous stem cell transplantation
Michele Cavo
1:57
Promising new combinations in the treatment of myeloma
Evangelos Terpos
1:48
Managing problems in treating CLL
Anna Schuh
1:18
Treatment options for leukemia patients who fail the standard of care
Paolo Ghia
1:13
Have novel drugs made stem cell transplantation obsolete?
David Maloney
3:51
Celebrating 60 years of successful allogeneic transplant at EHA 2017
Mohamad Mohty
5:22
Lymphoid Highlights from BSH 2017
George Follows
2:27
Indications for the use of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma
Anna Sureda
3:31
Advances in multiple myeloma treatment over the last years
Vincent Rajkumar
16:48
COMy 2017: Day 2 discussion on relapsed myeloma, treatment, plasma cell leukemia and awards
Arnon Nagler et al.
1:17
What types of post-transplant complications does the biobank project aim to improve?
Regis Peffault de Latour
1:38
Bettering the outcomes of transplant with the French biobank project
Regis Peffault de Latour
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

The content of VJHemOnc is intended for healthcare professionals